Saxagliptin N methyl impurity

Saxagliptin N-methyl impurity is a process-related API impurity arising from N-methylation at the pyrrolidinone nitrogen of the parent Saxagliptin molecule. This structural variant retains the core 5-(4-fluorophenyl)-1H-1,2,3-triazole-1-carboxamide scaffold but features a methyl-substituted pyrrolidin-3-yl group, disrupting the stereochemical integrity of the triazole-pyrrolidinone pharmacophore. The N-methyl substitution introduces steric hindrance, reducing hydrogen-bonding capacity compared to the native amide. This impurity serves as an HPLC reference standard for quantifying N-methylation byproducts during Saxagliptin synthesis.